Back
SPDR® S&P Health Care Services ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison
Sell
40
XHS
SPDR® S&P Health Care Services ETF
Last Price:
97.20
Seasonality Move:
0.35%
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.50
Seasonality Move:
-2.75%
Sell
40
SPDR® S&P Health Care Services ETF (XHS)
is a Sell
Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?
- The current SPDR® S&P Health Care Services ETF [XHS] share price is $96.99. The Score for XHS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- XHS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.69. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XHS Stock Price Chart
What is SPDR® S&P Health Care Services ETF's stock price today?
-
The SPDR® S&P Health Care Services ETF share price today is $96.99
The current trend is moderately bullish and XHS is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.69
The current trend is moderately bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
XHS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 50.58 | Buy |
| Chaikin Money Flow: | -1030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (96.17 - 98.39) | Sell |
| Bollinger Bands (100): | (90.19 - 96.85) | Buy |
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 58.29 | Buy |
| Chaikin Money Flow: | 4125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.57 - 15.57) | Buy |
| Bollinger Bands (100): | (13.97 - 15.41) | Buy |
XHS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97.28 | Sell |
| 20-day SMA: | 97.46 | Sell |
| 50-day SMA: | 96.45 | Buy |
| 200-day SMA: | 91.4 | Buy |
| 8-day EMA: | 97.35 | Sell |
| 20-day EMA: | 97.1 | Sell |
| 50-day EMA: | 95.97 | Buy |
| 200-day EMA: | 92.17 | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.64 | Buy |
| 20-day SMA: | 15.16 | Buy |
| 50-day SMA: | 14.87 | Buy |
| 200-day SMA: | 14.75 | Buy |
| 8-day EMA: | 15.55 | Buy |
| 20-day EMA: | 15.22 | Buy |
| 50-day EMA: | 14.9 | Buy |
| 200-day EMA: | 14.45 | Buy |
SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Health Care Services ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Range Cancer Therapeutics ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||